NDC 51662-1335

DILTIAZEM HCI

Diltiazem Hci

DILTIAZEM HCI is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diltiazem Hydrochloride.

• Product ID: 51662-1335_7d8e8b1e-f67c-57d2-e053-2991aa0a8d12
• NDC: 51662-1335
• Product Type: Human Prescription Drug
• Proprietary Name: DILTIAZEM HCI
• Generic Name: Diltiazem Hci
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2018-12-21
• Marketing Category: ANDA / ANDA
• Application Number: ANDA078538
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: DILTIAZEM HYDROCHLORIDE
• Active Ingredient Strength: 5 mg/mL
• Pharm Classes: Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51662-1335-1

5 mL in 1 VIAL (51662-1335-1)

• Marketing Start Date: 2018-12-21
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1335-1 [51662133501]

DILTIAZEM HCI INJECTION

• Marketing Category: ANDA
• Application Number: ANDA078538
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-12-21
• Inactivation Date: 2020-01-31
• Reactivation Date: 2020-02-07

Drug Details

Active Ingredients

Ingredient	Strength
DILTIAZEM HYDROCHLORIDE	5 mg/mL

OpenFDA Data

• SPL SET ID: 7d8e8b1e-f67b-57d2-e053-2991aa0a8d12
• Manufacturer:
  • HF Acquisition Co LLC, DBA HealthFirst
• UNII:
  • OLH94387TE
• RxNorm Concept Unique ID - RxCUI:
  • 1791229

Pharmacological Class

• Calcium Channel Antagonists [MoA]
• Calcium Channel Blocker [EPC]

NDC Crossover Matching brand name "DILTIAZEM HCI" or generic name "Diltiazem Hci"

NDC	Brand Name	Generic Name
51662-1335	DILTIAZEM HCI	DILTIAZEM HCI
51662-1457	DILTIAZEM HCI	DILTIAZEM HCI